Progyny, Inc. financial data

Symbol
PGNY on Nasdaq
Industry
Services-Misc Health & Allied Services, NEC
Location
1359 Broadway, 2 Nd Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
Auxogyn, Inc. (to 3/19/2015), Auxogyn Inc (to 9/16/2013)
Latest financial report
10-K - Q4 2024 - Mar 3, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 282 % -5.85%
Debt-to-equity 46.4 % +7.03%
Return On Equity 11.5 % -8.78%
Return On Assets 7.87 % -10.7%
Operating Margin 5.78 % +1.23%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 85.4M shares -11.5%
Common Stock, Shares, Outstanding 85.3M shares -11.5%
Entity Public Float 2.6B USD -21.2%
Common Stock, Value, Issued 9K USD 0%
Weighted Average Number of Shares Outstanding, Basic 85.8M shares -10.6%
Weighted Average Number of Shares Outstanding, Diluted 88.9M shares -11.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 1.17B USD +7.22%
Selling and Marketing Expense 63.9M USD +7.5%
General and Administrative Expense 122M USD +4.13%
Operating Income (Loss) 67.5M USD +8.48%
Nonoperating Income (Expense) 16.3M USD +137%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 83.2M USD +17.7%
Income Tax Expense (Benefit) 28.9M USD +234%
Net Income (Loss) Attributable to Parent 54.3M USD -12.4%
Earnings Per Share, Basic 0.6 USD/shares -9.09%
Earnings Per Share, Diluted 0.57 USD/shares -8.07%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 162M USD +66.8%
Accounts Receivable, after Allowance for Credit Loss, Current 235M USD -2.71%
Assets, Current 473M USD -26.2%
Deferred Income Tax Assets, Net 84.9M USD +16.2%
Property, Plant and Equipment, Net 12.4M USD +21.2%
Operating Lease, Right-of-Use Asset 17.3M USD -2.01%
Goodwill 15.5M USD +30.8%
Other Assets, Noncurrent 2.98M USD -12.3%
Assets 607M USD -19.8%
Accounts Payable, Current 95.1M USD -24.2%
Employee-related Liabilities, Current 14.6M USD +22.8%
Liabilities, Current 169M USD -9.32%
Operating Lease, Liability, Noncurrent 16.4M USD -4.8%
Liabilities 185M USD -8.93%
Accumulated Other Comprehensive Income (Loss), Net of Tax 39K USD -98.6%
Retained Earnings (Accumulated Deficit) 144M USD +60.4%
Stockholders' Equity Attributable to Parent 422M USD -23.7%
Liabilities and Equity 607M USD -19.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 25.7M USD +22.8%
Net Cash Provided by (Used in) Financing Activities -27.4M USD -1385%
Net Cash Provided by (Used in) Investing Activities 19.3M USD +19.9%
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 97.7M shares +1.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 17.7M USD -49.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 162M USD +66.8%
Deferred Tax Assets, Valuation Allowance 1.78M USD +247%
Deferred Tax Assets, Gross 91.8M USD +14.4%
Operating Lease, Liability 19.3M USD -0.61%
Payments to Acquire Property, Plant, and Equipment 850K USD -32.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 51.6M USD -19.9%
Lessee, Operating Lease, Liability, to be Paid 23.6M USD -2.58%
Property, Plant and Equipment, Gross 20.8M USD +33.8%
Operating Lease, Liability, Current 2.86M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3M USD +7.38%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.99M USD +33.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.37M USD -10.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3M USD +7.52%
Deferred Tax Assets, Operating Loss Carryforwards 5.58M USD -66.8%
Unrecognized Tax Benefits 603K USD +54.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3.01M USD +7.7%
Operating Lease, Payments 300K USD 0%
Depreciation, Depletion and Amortization 716K USD +32.3%
Deferred Tax Assets, Net of Valuation Allowance 90M USD +12.9%
Share-based Payment Arrangement, Expense 128M USD +4.5%